covid-19 Archives | Page 24 of 71

What’s in it for me? The Fundamentals and Implementing ISO 35001: Biorisk Management (588-621-21) (NEW 8/3, Webinar)

APHL

15 July 2021

PREVIOUSLY RECORDED WEBINAR: This webinar highlights the major components of the ISO 35001 standard and the value of laboratory implementation and describe different approaches to apply ISO 35001 in a laboratory setting including SARS-CoV-2 testing

keywords: biorisk, covid-19, standards, webinar

COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021 (NEW 8/3, Website, Publication)

CDC/MMWR

30 July 2021

Hause AM, Gee J, Baggs J, et al.

keywords: adolescents, covid-19, vaccination

Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021 (NEW 8/3, Website, Publication)

CDC/MMWR

30 July 2021

Brown CM, Vostok J, Johnson H, et al.

keywords: breakthrough case, covid-19, vaccination

Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network — United States, March 2021 (NEW 8/3, Website, Publication)

CDC/MMWR

30 July 2021

Lee JT, Althomsons SP, Wu H, et al.

keywords: covid-19, nursing home, senior living, treatment, vaccination

Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage (NEW 8/3, Website, Publication)

CDC/MMWR

27 July 2021

Christie A, Brooks JT, Hicks LA, et al.

keywords: covid-19, prevention, transmission, vaccination

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses (NEW 8/3, Website, Publication)

JAMA

23 July 2021

Ilies Benotmane, Gabriela Gautier, Peggy Perrin, et al

keywords: covid-19, mRNA, serology, vaccines

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

The Lancet

17 November 2020

Sinovac vaccine phase 1/2 clinical trial results

keywords: covid-19, vaccines

COVID-19 Vaccine Tracker

covid19.trackvaccines.org

9 July 2021

This project is supported by McGill University Interdisciplinary Initiative in Infection and Immunity (MI4). The COVID19 Vaccine Tracker is designed to provide clear, accessible, and comprehensive updates about COVID19 vaccine development and approvals worldwide. It includes links to phase 1, phase 2, phase 3 clinical trials.

keywords: covid-19, vaccines

COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS): updated guidance regarding myocarditis and pericarditis reported with COVID-19 mRNA vaccines

World Health Organization (WHO)

9 July 2021

Updated guidance regarding myocarditis and pericarditis reported with COVID-19 mRNA vaccines

keywords: covid-19, mycocarditis, vaccines

Efficacy of Portable Air Cleaners and Masking for Reducing Indoor Exposure to Simulated Exhaled SARS-CoV-2 Aerosols — United States, 2021

CDC/MMWR

9 July 2021

Lindsley WG, Derk RC, Coyle JP, et al.
A combination of HEPA air cleaners and universal masking reduced exposure by up to 90%.

keywords: covid-19, HVAC, transmission

Resources with keywords: covid-19